Make Millions Available for Esophageal Cancer Research
What our Campaign Will Do: The United States Congress appropriated $90 million dollars this year for a Cancer Research Fund administered by the Department of Defense. The only researchers allowed to apply for those funds must be working on 16 specific cancer designations. Today, Esophageal Cancer is not on that list. But our campaign seeks to change that – and we think we have a good chance of making it happen. When we do, millions of dollars in cancer research funding could become available to researchers in Esophageal Cancer who today struggle to find a source to finance the work they need to do.
If we can finish raising the $50,000 needed by November 1st, we will launch our Advocacy Campaign for Esophageal Cancer Research Funding at the start of the New Year. We need to be prepared to hit the ground running when the new Congress is sworn in. These funds will be used to hire the experts we need to navigate on Capitol Hill and to reach out to families and patients affected by Esophageal Cancer to provide opportunities to make their voices heard and training on how best to do that.
Research funding makes a difference. In 2016, the National Cancer Institute spent $1,669 on medical research into Esophageal Cancer for each death due to this devastating disease. It amounted to just one-half of a percent of the total Federal cancer research budget. But Esophageal Cancer is responsible for 2.6% of all of the cancer deaths in this country. Compare that to the $12,802 spent that year on breast cancer research for every death caused by that terrible disease. That amounts to 9.9% of the Federal cancer research budget. Breast cancer causes 6.8% of all U.S. cancer deaths, even though many more are diagnosed with the disease. It shows what a difference research funding can make! A breast cancer diagnosis used to be viewed as a death sentence – today it’s survival rate is 89.7%. The survival rate for Esophageal Cancer is under 19%. We desperately need funding for more research into Esophageal Cancer. Adding it to this Cancer Research Fund is our best hope to do that.